Pharmacokinetic Interactions between Buprenorphine/Naloxone and Raltegravir in Subjects Receiving Chronic Buprenorphine/Naloxone Treatment

Author： Douglas Bruce R.  

Publisher： Informa Healthcare

ISSN： 0095-2990

Source： The American Journal of Drug and Alcohol Abuse, Vol.39, Iss.2, 2013-03, pp. : 80-85

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spotlight on Buprenorphine/Naloxone in the Treatment of Opioid Dependence†

By Orman Jennifer S.   Keating Gillian M.  

CNS Drugs, Vol. 23, Iss. 10, 2009-10 ,pp. : 899-902

Adis International

Access to resources Recommend Favorite

Tipranavir//Ritonavir Induction of Buprenorphine Glucuronide Metabolism in HIV-Negative Subjects Chronically Receiving Buprenorphine//Naloxone

By Bruce R. Douglas   Moody David E.   Fang Wenfang B.   Chodkowski Diane   Andrews Laurie   Friedland Gerald H.  

The American Journal of Drug and Alcohol Abuse, Vol. 37, Iss. 4, 2011-07 ,pp. : 224-228

Informa Healthcare

Access to resources Recommend Favorite

Buprenorphine/Naloxone: A Review of its Use in the Treatment of Opioid Dependence

By Orman Jennifer S.   Keating Gillian M.  

Drugs, Vol. 69, Iss. 5, 2009-03 ,pp. : 577-607

Adis International

Access to resources Recommend Favorite

Less Pain, More Gain: Buprenorphine-Naloxone and Patient Retention in Treatment

By Renzelli Cara M.   Capretto Neil A.  

Journal of Addictive Diseases, Vol. 25, Iss. 3, 2006-08 ,pp. : 97-104

Haworth Press

Access to resources Recommend Favorite

Buprenorphine/naloxone reduces drug abuse, costs

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 552, 2008-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite